Antidepressants elevate GDNF expression and release from C6 glioma cells in a β-arrestin1-dependent, CREB interactive pathway
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Glial cell line-derived neurotrophic factor (GDNF), essential for neuronal survival, plasticity and development, has been implicated in the mechanism of action of antidepressant drugs (ADs). β-arrestin1, a member of the arrestin protein family, was found to play a role in AD mechanism of action. The present study aimed at evaluating whether the effect of ADs on GDNF in C6 rat glioma cells is exerted through a β-arrestin1-dependent, CREB-interactive pathway. For chronic treatment, C6 rat glioma cells were treated for 3 d with different classes of ADs: imipramine - a non-selective monoamine reuptake inhibitor, citalopram - a serotonin selective reuptake inhibitor (SSRI) or desipramine - a norepinephrine selective reuptake inhibitor (NSRI) and compared to mood stabilizers (lithium and valproic acid) or to the antipsychotic haloperidol. Only ADs significantly elevated β-arrestin1 levels in the cytosol, while reducing phospho-β-arrestin1 levels in the cell nuclear fraction. ADs significantly increased both GDNF expression and release from the cells, but were unable to induce such effects in β-arrestin1 knock-down cells. Chronic AD treatment significantly increased CREB phosphorylation without altering the level of total CREB in the nuclear fraction of the cells. Moreover, treatment with ADs significantly increased β-arrestin1/CREB interaction. These findings support the involvement of β-arrestin1 in the mechanism of action of ADs. We suggest that following AD treatment, β-arrestin1 generates a transcription complex involving CREB essential for GDNF expression and release, thus enhancing GDNF's neuroprotective action that promotes cellular survival and plasticity when the survival and function of neurons is compromised as occurs in major depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Function and regulation of CREB family transcription factors in the nervous system
Lonze, B. E., & Ginty, D. D. (2002) · Neuron · doi:10.1016/s0896-6273(02)00828-0 · Cited by 2,127 · cited 4×
“Received 16 August 2010 ; Reviewed 6 October 2010 ; Revised 12 November 2010 ; Accepted 29 November 2010 ; First published online 12 January 2011 Key words : Antidepressants, b-arrestin1, CREB, GDNF, glial cells.”
BackgroundMethodInfluentialStress, Depression, and Neuroplasticity: A Convergence of Mechanisms
Pittenger, C., & Duman, R. S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301574 · Cited by 1,795 · cited 2×
“Received 16 August 2010 ; Reviewed 6 October 2010 ; Revised 12 November 2010 ; Accepted 29 November 2010 ; First published online 12 January 2011 Key words : Antidepressants, b-arrestin1, CREB, GDNF, glial cells.”
BackgroundMethodGlial reduction in the subgenual prefrontal cortex in mood disorders
Öngür, D., Drevets, W. C., & Price, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13290 · Cited by 1,525 · cited 2×
“For example, low numbers of glial cells were found in the cerebral cortex of patients with major depression (Ongur et al. 1998 ; Rajkowska et al. 1999).”
BackgroundRajkowska, G., Miguel-Hidalgo, J. J., Wei, J., Dilley, G., Pittman, S. D., Meltzer, H. Y., Overholser, J. C., Roth, B. L., & Stockmeier, C. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00041-4 · Cited by 1,477 · cited 2×
“For example, low numbers of glial cells were found in the cerebral cortex of patients with major depression (Ongur et al. 1998 ; Rajkowska et al. 1999).”
BackgroundDavid, D. J., Samuels, B. A., Rainer, Q., Wang, J.-W., Marsteller, D., Mendez, I., Drew, M., Craig, D. A., Guiard, B. P., Guilloux, J.-P., et al. (2009) · Neuron · doi:10.1016/j.neuron.2009.04.017 · Cited by 1,267
Role of neurotrophic factors in depression
CASTREN, E., VOIKAR, V, & RANTAMAKI, T. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.08.009 · Cited by 667 · cited 2×
“…for the formulation of new hypotheses that assign the pathophysiological basis of major depression to impaired neuroplasticity (for review see Castren et al. 2007 ; Pittenger & Duman, 2008) which is restored by antidepressant-increased neurogenesis and gliogenesis (for review see Banasr &…”
BackgroundMethodCzéh, B., Simon, M., Schmelting, B., Hiemke, C., & Fuchs, E. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300982 · Cited by 434 · cited 2×
“Fluoxetine (Czeh et al. 2006) and clomipramine (Liu et al.”
BackgroundTardito, D., Perez, J., Tiraboschi, E., Musazzi, L., Racagni, G., & Popoli, M. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.1.7 · Cited by 303 · cited 3×
“CREB plays a major role in the transcription of neurotrophic factors in general (Baecker et al. 1999; Cen et al. 2006 ; Koyama et al. 2004) including BDNF (Lonze & Ginty, 2002) and GDNF (Cen et al. 2006), and also following antidepressant treatment (Hisaoka et al. 2008 ; Tardito et al. 2006, 2009).”
BackgroundInfluentialCellular and molecular mechanisms in the long-term action of antidepressants.
Racagni, G., & Popoli, M. (2008) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2008.10.4/gracagni · Cited by 192 · cited 4×
“Received 16 August 2010 ; Reviewed 6 October 2010 ; Revised 12 November 2010 ; Accepted 29 November 2010 ; First published online 12 January 2011 Key words : Antidepressants, b-arrestin1, CREB, GDNF, glial cells.”
BackgroundMethodInfluentialMAP Kinase Activation by Fluoxetine and Its Relation to Gene Expression in Cultured Rat Astrocytes
Mercier, G., Lennon, A. M., Renouf, B., Dessouroux, A., Ramaugé, M., Courtin, F., & Pierre, M. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:24:2:207 · Cited by 176 · cited 2×
“It is well documented that ADs increase GDNF levels (Hisaoka et al. 2001, 2007 ; Mercier et al. 2004) and recently it was found that depressed patients demonstrated lower levels of serum GDNF (Takebayashi et al. 2006 ; Zhang et al. 2008) which were increased following antidepressant treatment…”
Background
Cited by
Neuroplasticity and the next wave of antidepressant strategies
Hayley, S., & Litteljohn, D. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00218 · Cited by 92
“…antidepressants were found to not only normalize stressor-induced reductions in circulating GDNF (Angelucci et al., 2003) but also to induce the neurotrophin’s synthesis and release from cultured glioma cells and astrocytes (Mercier et al., 2004; Golan et al., 2011; Di Benedetto et al., 2012).”
BackgroundCalati, R., Crisafulli, C., Balestri, M., Serretti, A., Spina, E., Calabrò, M., Sidoti, A., Albani, D., Massat, I., Höfer, P., et al. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.03.005 · Cited by 45
Ma, J., Wang, L., Yang, Y., Qiao, Z., Fang, D., Qiu, X., Yang, X., Zhu, X., He, J., Pan, H., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0170994 · Cited by 26
Metadata
- Authors
- Golan, M., Schreiber, G., & Avissar, S.
- Venue
- The International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-01-12
- Volume
- 14
- Issue
- 10
- Pages
- 1289-1300
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- OpenAlex
- W1999206875
- Cited by
- 54
- References
- 14
- FWCI
- 3.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antidepressants elevate GDNF expression and release from C6 glioma cells in a β-arrestin1-dependent, CREB interactive pathway. https://app.cochat.ai/papers/10.1017/s1461145710001550
- The paper
- Golan, M., Schreiber, G., & Avissar, S. (2011). Antidepressants elevate GDNF expression and release from C6 glioma cells in a β-arrestin1-dependent, CREB interactive pathway. The International Journal of Neuropsychopharmacology. https://doi.org/10.1017/s1461145710001550
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.